期刊文献+

可疑肾动脉狭窄患者行肾动脉支架植入及开搏通试验前后脑钠肽的变化

Changes in brain natriuretic peptide levels before and after Capoten test as well as renal artery intervention in patients with suspected renal artery stenosis
下载PDF
导出
摘要 选择2007-06/2008-03本院心内科收治的可疑肾动脉狭窄引起的高血压患者40例,男28例,女12例,平均年龄(60.0±15.6)岁。行开搏通试验及肾动脉造影,测定患者行开搏通试验及肾动脉支架植入前后脑钠肽的变化。40例可疑肾动脉狭窄行开搏通试验者,30例试验阳性,10例试验阴性;30例试验阳性者其试验前后脑钠肽含量差异具有显著性意义(P<0.05);10例阴性患者其试验前后脑钠肽含量差异无显著性意义(P>0.05)。对30例阳性患者行肾动脉造影,23例行支架植入,支架植入前后脑钠肽含量差异具有显著性意义(P<0.05);对10例阴性患者行肾动脉造影,3例行支架植入,支架植入前后脑钠肽含量差异无显著性意义(P>0.05)。结果说明对于高度可疑肾动脉狭窄患者,脑钠肽水平可用于诊断及评价肾动脉狭窄患者支架植入的可能疗效。 Forty patients with hypertension suspected to stenosis of renal artery were selected from Department of Cardiology, General Hospital of Chinese PLA between June 2007 and March 2008, including 28 males and 12 females with an average age of (60.0±15.6). Capoten test and renal artery angioplasty were performed in all patients to detect brain natriuretic peptide changes before and after the Capoten test and renal artery stent implantation. Among 40 patients underwent Capoten test, 30 showed positive result and 10 negative. The levels of brain natriuretic peptide before and after Capoten test in patients with positive result were statistically different (P 〈 0.05). But there was no statistical difference in patients with negative Capoten test (P 〉 0.05). Among thirty patients with positive Capoten test undergoing renal artery angioplasty, twenty-three patients underwent stent implantation, and their brain natriuretic peptide showed statistical differences between before and after stent implantation (P 〈 0.05). Among ten patients with negative Capoten test undergoing renal artery angioplasty, three patients underwent stent implantation, and there was no significant difference in brain natriuretic peptide between before and after stent implantation (P 〉 0.05). The results of the study show that levels of brain natriuretic peptide can be used to evaluate possible effect of stent implantation for patients with hypertension suspected to stenosis of renal artery.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第39期7688-7690,共3页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献10

  • 1Bokhari SW, Faxon DE Current advances in the diagnosis and treatment of renal artery stenosis. Rev Cardiovasc Med 2004;5(4): 204-215.
  • 2Olin JW. Renal artery disease: diagnosis and management. Mt Sinai J Med 2004;71 (2):73-85.
  • 3Silva JA, Chan AW, White CJ, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005;111 (3):328-333.
  • 4Mussalo H, Vanninen E, Ikaheimo R, et al. NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney Blood Press Res 2003;26(1):34-41.
  • 5McCullough PA, Kuncheria J, Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardlivasc Med 2003;4 Suppl 7:S3-S12.
  • 6中华人民共和国国务院.医疗机构管理条例.1994-09-01.[2006-08-01].http://www.gov.cn/banshi/2005-08/01/content_19113.htm
  • 7Missouris CG, Belli AM, MacGregor GA. "Apparent" heart failure: a syndrome caused by renal artery stenoses. Heart 2000;83(2): 152-155.
  • 8McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003;41(3):571-579.
  • 9Bibbins-Domingo K, Ansari M, Schiller NB, et al. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2003;108(24):2987-2992.
  • 10Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355(9210): 1126-1130.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部